Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)—upcoming
Deadline: June 05, 2018
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum award period is 5 years depending on the policy of each NIH Institute. Applicants are encouraged to review the current funding policy of each NIH Institute
To encourage collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promising tools, methods and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research and is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical or translational science.
- Clinical trials optional
- See FOA link for IC-specific interests including those of NCI, NIAID, NIAMS, NICHD, NIDCR and NINDS
- Companion FOAs available
- See FOA for details on allowable clinical trials